A modified anticancer drug can simultaneously target tumor sites and show whether or not it is working
Cancer drugs can be modified to specifically target tumor sites to help personalize cancer treatment. And while it is relatively easy to determine if the drugs have been delivered to the correct location, it is more difficult to monitor their therapeutic success. Now, a team led by Bin Liu from the A*A*STAR Institute of Materials Research and Engineering in Singapore, in collaboration with Ben Zhong Tang at Hong Kong University of Science and Technology, has developed an anticancer drug with an inbuilt mechanism that shows if it is working1.
Platinum-based drugs are effective against many cancers, killing cells by triggering cellular suicide, or apoptosis. These drugs can, however, have severe side effects. Nontoxic forms can be modified, as a type of prodrug, to convert to their toxic form only after entering the targeted tumor cells, so as not to harm noncancerous cells.
Liu and colleagues went one step further by modifying a platinum-based prodrug to not only target tumor cells effectively, but also show whether or not it was having the desired effect. According to Liu, this added feature could be crucial for improving cancer treatment.
“Early evaluation of a patient’s response to a specific cancer therapy is important in clinical applications because it can minimize the duration of ineffective courses,” explains Liu. “The effectiveness of cancer treatment is commonly evaluated using magnetic resonance imaging to measure the tumor size, but this is unsatisfactory as the change in size is not obvious at the early stages of therapy.”
In their new system, Liu and her team included an apoptosis sensor that is released when the prodrug converts to its toxic form inside the targeted tumor cells. The toxic form triggers cell apoptosis and activates an enzyme called caspase 3, which then cleaves the apoptosis sensor and causes it to fluoresce green. This provides a visual signal that the drug is killing the cells.
The Latest on: Anticancer drug
via Google News
The Latest on: Anticancer drug
- RTP pharma to see $20M infusion on heels of drug winning approvalon September 21, 2022 at 12:17 pm
After falling short on two previous attempts, a drugmaker in Research Triangle Park has finally secured FDA approval.
- Fennec wins approval of first drug for chemotherapy-induced hearing loss in childrenon September 21, 2022 at 9:21 am
The drug, Pedmark, has been in development for more than two decades and was previously rejected twice by U.S. regulators.
- Insights into the mechanism of ultraviolet light damage and cancer lesions may contribute to anticancer therapyon September 21, 2022 at 6:12 am
A team led by researchers from Nagoya University in Japan has discovered new pathways that cells use to repair themselves following exposure to ultraviolet (UV) light, and a new agent involved in ...
- FDA-approved anti-sedative could alleviate common side effects of cancer treatmentson September 20, 2022 at 6:21 pm
Researchers in China have discovered that inhibiting a protein called the GABAA receptor can protect intestinal stem cells from the toxic effects of chemotherapy and radiotherapy.
- Discovery explains cancer chemotherapy resistance, offers solutionon September 20, 2022 at 9:25 am
Researchers have uncovered a novel pathway that explains how cancer cells become resistant to chemotherapies, which in turn offers a potential solution for preventing chemo-resistance.
- Antibody Drug Conjugates ‘Make Chemotherapy Targeted’ for Patients With Canceron September 19, 2022 at 2:00 pm
Antibody drug conjugates have changed the cancer treatment landscape by offering a way to deliver chemotherapy in a more targeted fashion, sparing healthy cells and cutting down on side effects, ...
- Anticancer Drugs Market 2022 Growth Opportunities, Development Status, Future Plan Analysis, Industry Trends, Size, Share, Forecast to 2029on September 16, 2022 at 2:13 am
This report provides comprehensive analysis of the Anticancer Drugs Market emerging Point-of-Care testing market ...
- Potential New Drug Target Could Boost Effectiveness of Chemotherapy Drugson September 15, 2022 at 8:20 am
Researchers at The University of Texas at Austin have discovered that a large family of reverse transcriptases (RTs)—enzymes that are found in all organisms and have been extensively studied for more ...
- Essential Drugs List Gets Updated With New Diabetes and Anti-Cancer Drugson September 15, 2022 at 4:04 am
How many drugs have been listed in the National List of Essential Medicines 2022? 34 new medicines including some anticancer, and diabetic drugs, and dropped 26 old ones.
- Anti-cancer drugs among 34 added to essentials liston September 13, 2022 at 4:25 pm
The Union health ministry released the NLEM 2022 list with 34 additions, including the cancer drugs Bendamustine Hydrochloride, HCI Trihydrate, Lenalidomide and Leuprolide Acetate, taking the number ...
via Bing News